SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
MHS Analysis & Videos »
MHS: Bull or Bear?
Health Benefit Providers Index Drops on Reform Concerns
MHS
|
|
|
+14.60%
in
126 days
The accompanying table includes 38 companies in the ETF Innovators Health Benefit Providers Index, which was down sharply in the past week and has lost 14% of its market value to a level of 192,305 since I last wrote about the group five weeks ago. <> <> The uncertain future for health insurers and benefit providers that I wrote about previously came to a head this week with plans by President Obama for healthcare reform aimed at cutting health costs by favoring generic drug makers and smaller Medicare Advantage payments to private insurers, along with smaller increases...
|
Healthcare Investing Trends in '09 and Beyond
MHS
|
|
|
-16.07%
in
21 days
(closed on 02/28/09)
<> While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector.
Global Health IT : The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a pro< />< />< />< /><>< />< />< />< /><><>< />< /><>< />< />< />< /><>...
|
Five Top Rated Healthcare Cost Containment Stocks
MHS
|
|
|
+9.49%
in
38 days
(closed on 02/07/09)
The table at my website link below includes statistics and the top five rated companies in the ETF Innovators [ETFI] Global Healthcare Cost Containment Index. The index includes generic drug companies such as Teva Pharma (TEVA) and Perrigo (PRGO) as well as pharmacy benefit managers such as Express Scripts (ESRX), which share the common theme of promoting the use of generics to lower healthcare costs. http://www.etfinnovators.com/2008/12/five-top-rated-healthcar... <> <> The Top 40 Rated companies outpaced the overall market and benchmark healthcare ETFs over the past year w...
|
Generic Cardio Drugs Equal Brands - JAMA
MHS
|
|
|
+12.07%
in
28 days
(closed on 12/30/08)
<> 
A meta-analysis review of clinical studies published in peer-reviewed journals was featured today in The Journal of the American Medical Association [JAMA] and concluded that cost-saving generics used to treat a variety of cardiovascular conditions produced equivalent clinical outcomes to higher cost brand name drugs. Despite this clinical evidence, the review notes that a majority (53%) of the 43 editorials analyzed had a negative opinion on generic substitution.
While there are currently no ETFs on the market w...
|
A New Global Healthcare Composite Index
MHS
|
|
|
+8.16%
in
4 days
(closed on 11/27/08)
<> 
The accompanying table [click to enlarge or download] presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 50 top rated companies on an equal weight basis from each of the 10 new healthcare indexes as an alternative strategy to existing health composite ETFs with highly correlated returns and over-weight exposure to th...
|
A New Index of Healthcare Cost Containment Companies
MHS
|
|
|
+2.09%
in
3 days
(closed on 11/23/08)
<> 
<> The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.
Generic Healthcare Products: This category includes generic prescription a...
|
ETFI Global Healthcare Sector PerformIdex
MHS
|
|
|
-7.91%
in
6 days
(closed on 11/20/08)
<> 
The accompanying table presents the top five rated companies with market caps of at least $250 million (USD) from each of the nine new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 400 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 45 top rated companies ranging from small-caps to mega-caps from the following underlying healthcare indexes:
1.) ETFI Global Hospitals – Fresenius Medical (FMS)
2.) <> ETFI New Drug Regulatory Catalys...
|
Teva Beats on Profits: A Biogeneric Boon in '09?
MHS
|
|
|
-0.66%
in
8 days
(closed on 11/14/08)
<> 
<> Teva Pharma (TEVA) posted 3Q08 results this morning which beat consensus profit estimates by a penny at 72 cents per share on an adjusted basis with record sales coming in slightly below estimates at $2.84B versus $2.9B expected. Revenue increased by 20% while GAAP net income of $637M rose by 21% from the year-ago period. Results were driven by the proprietary multiple sclerosis drug Copaxone, which posted sales of $562M, representing a 28% increase from the year-ago period. Cash flow from operations more than dou...
|
Medco Health: Still the right prescription for portfolios
MHS
-4.84%
in
382 days
Filed under: Stocks to Buy The market's choppy/consolidating tone, combined with the slow-growth/no-growth U.S. economy, suggests it is prudent to add a defensive stock or two to your portfolio, and with the aforementioned in mind, Medco Health Solutions is worth a review.
Medco Health Solutions (NYSE: MHS) is one of the largest U.S. pharmacy benefit managers, with services provided to client/member PBMs and physicians/pharmacies. (Note: Medco Health's shares split 2-for-1 on January 10, 2008.)
Analysts like Medco's high account retention, new business wins, economies of scale, and the company...
|
Earnings Review: Ignoring Media and Government Reports
MHS
|
|
|
-8.73%
in
429 days
First the market - we continue to cling in a tiny range... can't get
over that S&P 1400 level no matter what.<!--more--> All week everyone sits on
their hands and waits for the Gods from D.C. to tell us what they do
with the peons... we expect 25 basis points and then statements saying
balances are risked, we care about inflation blah blah. Or maybe even
no cut. Either way it doesn't matter much - these are long term
situations yet not a trader on Wall Street can hit buy or sell this
week until they see the action. <> This has to be the most telegraphed "weare stopping after this meeting" I've...
|
Solid Healthcare Play
MHS
|
|
|
-49.72%
in
111 days
(closed on 05/15/08)
Medco is positioned well in the generic drug market and with everyone cutting costs lately the demand for generics should go up. The Baby Boomer generation on a fixed income will also fuel the fire for generic drugs. Mail order is a HUGE plus since there is no worry about the overhead when it comes to retail stores such as Rite-Aid, CVS, Wallgreens, etc.
|
People Bullish on MHS
People Bearish on MHS
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Be the first to start a discussion and earn 2 points.
More Resources
|
About Medco Health Solutions Inc.
- Answers.com
